Matthew M. Champion

Matthew M. Champion

Auto-generated profile, based on publicly available information

Matthew M. Champion

Department of Chemistry and Biochemistry, University of Notre Dame

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2006 in Science
Verified
Journal Article
Closed access
PDF file
PCPatricia A. DiGiuseppe Champion
Patricia A. DiGiuseppe Champion
SSSarah A. Stanley
Sarah A. Stanley
MCMatthew M. Champion
Matthew M. Champion
EBEric J. Brown
Eric J. Brown
JCJeffery S. Cox
Jeffery S. Cox
Mycobacterium tuberculosis uses the ESX-1/Snm system [early secreted antigen 6 kilodaltons (ESAT-6) system 1/secretion in mycobacteria] to deliver virulence factors into host macrophages during infection. Despite its essential role in virulence, the mechanism of ESX-1 secretion is unclear. We found that the unstructured C terminus of the CFP-10 substrate was recognized by Rv3871, a cytosolic component of the ESX-1 system that itself interacts with the membrane protein Rv3870. Point mutations in the signal that abolished binding of CFP-10 to Rv3871 prevented secretion of the CFP-10 (culture filtrate protein, 10 kilodaltons)/ESAT-6 virulence factor complex. Attachment of the signal to yeast ubiquitin was sufficient for secretion from M. tuberculosis cells, demonstrating that this ESX-1 signal is portable.

24 August 2009 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
PCPatricia A. DiGiuseppe Champion
Patricia A. DiGiuseppe Champion
MCMatthew M. Champion
Matthew M. Champion
PMPaolo Manzanillo
Paolo Manzanillo
JCJeffery S. Cox
Jeffery S. Cox
Summary: The ESX‐1 secretion system of Mycobacterium tuberculosis delivers bacterial virulence factors to host cells during infection. The most abundant factor, the ESAT‐6/CFP‐10 dimer, is targeted for secretion via a C‐terminal signal sequence on CFP‐10 that is recognized by the cytosolic ATPase, Rv3871. However, the selection determinants for other ESX‐1 substrates appear to be more complex. Some substrates, such as ESAT‐6, are secreted despite lacking signal sequences. Furthermore, all substrates require targeting of the other ESX‐1 secreted proteins, a distinguishing feature of this system. How ESX‐1 substrates are selected and the basis for co‐dependent secretion is unknown. Here we show that the EspC substrate interacts with Rv3868, a cytosolic AAA ATPase, through its C‐terminus. Swapping the C‐termini of EspC and CFP‐10 revealed that these signals are functionally distinct, suggesting that the proteins are targeted via interactions with different ATPases. Surprisingly, biochemical purification experiments demonstrate that these substrates and ATPases form multi‐protein complexes inside the cell and identified a new secreted substrate. By interfering with this protein interaction network, we have partially uncoupled co‐dependent substrate secretion. Our results suggest that proper functioning of the ESX‐1 pathway requires the interaction of multiple ESX‐1 substrates and components prior to their secretion. Ultimately, understanding the details of ESX‐1 targeting may allow for engineering of better vaccines to prevent tuberculosis.

19 September 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SFShan Feng
Shan Feng
XCXi Cheng
Xi Cheng
LZLin Zhang
Lin Zhang
XLXuemin Lu
Xuemin Lu
SCSeema Chaudhary
Seema Chaudhary
Xin LuXin Lu
Xin Lu
Potent immunosuppressive mechanisms within the tumor microenvironment contribute to the resistance of aggressive human cancers to immune checkpoint blockade (ICB) therapy. One of the main mechanisms for myeloid-derived suppressor cells (MDSCs) to induce T cell tolerance is through secretion of reactive nitrogen species (RNS), which nitrates tyrosine residues in proteins involved in T cell function. However, so far very few nitrated proteins have been identified. Here, using a transgenic mouse model of prostate cancer and a syngeneic cell line model of lung cancer, we applied a nitroproteomic approach based on chemical derivation of 3-nitrotyrosine and identified that lymphocyte-specific protein tyrosine kinase (LCK), an initiating tyrosine kinase in the T cell receptor signaling cascade, is nitrated at Tyr394 by MDSCs. LCK nitration inhibits T cell activation, leading to reduced interleukin 2 (IL2) production and proliferation. In human T cells with defective endogenous LCK, wild type, but not nitrated LCK, rescues IL2 production. In the mouse model of castration-resistant prostate cancer (CRPC) by prostate-specific deletion of Pten, p53, and Smad4, CRPC is resistant to an ICB therapy composed of antiprogrammed cell death 1 (PD1) and anticytotoxic–T lymphocyte-associated protein 4 (CTLA4) antibodies. However, we showed that ICB elicits strong anti-CRPC efficacy when combined with an RNS neutralizing agent. Together, these data identify a previously unknown mechanism of T cell inactivation by MDSC-induced protein nitration and illuminate a clinical path hypothesis for combining ICB with RNS-reducing agents in the treatment of CRPC. Significance Immune checkpoint blockade (ICB) to reinvigorate cytotoxic T lymphocytes using antibodies against CTLA4 or PD1 generates durable therapeutic responses in patients across a variety of cancer types. However, some cancers such as castration-resistant prostate cancer (CRPC) show overwhelming resistance to ICB. Here, we develop a nitroproteomic approach and uncover a potential mechanism for the immunotherapy resistance where a key protein for T cell activation, lymphocyte-specific protein tyrosine kinase (LCK), is nitrated and inactivated by myeloid-derived suppressor cell–generated reactive nitrogen species (RNS) in the resistant tumor. An agent that neutralizes RNS significantly sensitizes CRPC to ICB therapy in a mouse model. Therefore, our studies illuminate a clinical path hypothesis for combining ICB with RNS-reducing agents in the treatment of ICB-resistant cancers.

13 September 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TNTrung T. Nguyen
Trung T. Nguyen
DDDerong Ding
Derong Ding
WWWilliam R. Wolter
William R. Wolter
RPRocio L. Pérez
Rocio L. Pérez
MCMatthew M. Champion
Matthew M. Champion
MCMayland Chang
Mayland Chang

19 December 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
YLYihan Li
Yihan Li
MCMatthew M. Champion
Matthew M. Champion
LSLiangliang Sun
Liangliang Sun
PCPatricia A. DiGiuseppe Champion
Patricia A. DiGiuseppe Champion
RWRoza Wojcik
Roza Wojcik
NDNorman J. Dovichi
Norman J. Dovichi

29 August 2013 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSamuel S. C. Rund
Samuel S. C. Rund
NBNicolle A. Bonar
Nicolle A. Bonar
MCMatthew M. Champion
Matthew M. Champion
JGJohn P. Ghazi
John P. Ghazi
CHCameron M. Houk
Cameron M. Houk
Giles E. DuffieldGiles E. Duffield
Giles E. Duffield
We recently characterized 24-hr daily rhythmic patterns of gene expression in Anopheles gambiae mosquitoes. These include numerous odorant binding proteins (OBPs), soluble odorant carrying proteins enriched in olfactory organs. Here we demonstrate that multiple rhythmically expressed genes including OBPs and takeout proteins, involved in regulating blood feeding behavior, have corresponding rhythmic protein levels as measured by quantitative proteomics. This includes AgamOBP1, previously shown as important to An. gambiae odorant sensing. Further, electrophysiological investigations demonstrate time-of-day specific differences in olfactory sensitivity of antennae to major host-derived odorants. The pre-dusk/dusk peaks in OBPs and takeout gene expression correspond with peak protein abundance at night and in turn coincide with the time of increased olfactory sensitivity to odorants requiring OBPs and times of increased blood-feeding behavior. This suggests an important role for OBPs in modulating temporal changes in odorant sensitivity, enabling the olfactory system to coordinate with the circadian niche of An. gambiae.